Altretamine (also hexalen) is an antineoplastic agent.
It was approved by the FDA in 1990.
It is used to treat refractory ovarian cancer.
It is not considered a first-line treatment, but it can be useful as salvage therapy. It also has the advantage of being less toxic than other drugs used for treating refractory ovarian cancer.
The precise mechanism by which altretamine exerts its anti-cancer effect is unknown, but it is classified by MeSH as a...
more
Altretamine (also hexalen) is an antineoplastic agent.
It was approved by the FDA in 1990.
It is used to treat refractory ovarian cancer.
It is not considered a first-line treatment, but it can be useful as salvage therapy. It also has the advantage of being less toxic than other drugs used for treating refractory ovarian cancer.
The precise mechanism by which altretamine exerts its anti-cancer effect is unknown, but it is classified by MeSH as an alkylating antineoplastic agent. Hydroxymethylmelamines are the active metabolite.
Side effects include nausea, vomiting, diarrhea, and neurotoxicity. Toxicity can be decreased using pyridoxine.
less
